Chemical Compound Review:
Zoprace (2S,4S)-1-[(2R)-2-methyl-3...
Synonyms:
Zofenopril, Zofenoprilum, TPC-I147, Zofenil (TN), CHEMBL331378, ...
Zanchetti,
Parati,
Malacco,
Cominacini,
Pasini,
Garbin,
Evangelista,
Crea,
Tagliacozzi,
Nava,
Davoli,
LoCascio,
Mitchell,
Pfeffer,
Finn,
Pfeffer,
Brilla,
Dal Bo,
Mazzucchelli,
Marzo,
- Zofenopril after anterior myocardial infarction. Mörike, K., Mikus, G. N. Engl. J. Med. (1995)
- Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats. Mitchell, G.F., Pfeffer, M.A., Finn, P.V., Pfeffer, J.M. Circulation (1996)
- Zofenopril plus hydrochlorothiazide: Combination therapy for the treatment of mild to moderate hypertension. Zanchetti, A., Parati, G., Malacco, E. Drugs (2006)
- Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril. van Wijngaarden, J., Pinto, Y.M., van Gilst, W.H., de Graeff, P.A., de Langen, C.D., Wesseling, H. Cardiovasc. Res. (1991)
- Clinical pharmacology of the ACE inhibitors. Fyhrquist, F. Drugs (1986)
- Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction. The SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation. Borghi, C., Ambrosioni, E., Magnani, B. Am. J. Cardiol. (1996)
- The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. Ambrosioni, E., Borghi, C., Magnani, B. N. Engl. J. Med. (1995)
- Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. Binkley, P.F., Haas, G.J., Starling, R.C., Nunziata, E., Hatton, P.A., Leier, C.V., Cody, R.J. J. Am. Coll. Cardiol. (1993)
- Angiotensin converting enzyme inhibition at rest and during exercise in congestive heart failure. Kelbaek, H., Agner, E., Wroblewski, H., Vasehus Madsen, P., Marving, J. Eur. Heart J. (1993)
- Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs. Brilla, C.G. Cardiovasc. Res. (2000)
- Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection. Grover, G.J., Sleph, P.G., Dzwonczyk, S., Wang, P., Fung, W., Tobias, D., Cushman, D.W. J. Pharmacol. Exp. Ther. (1991)
- Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action. Ferrari, R., Cargnoni, A., Curello, S., Ceconi, C., Boraso, A., Visioli, O. J. Cardiovasc. Pharmacol. (1992)
- Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study. Borghi, C., Ambrosioni, E. Am. Heart J. (2003)
- Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party. Ambrosioni, E., Borghi, C., Magnani, B. Am. J. Cardiol. (1991)
- Sites of first-pass bioactivation (hydrolysis) of orally administered zofenopril calcium in dogs. Morrison, R.A., Burkett, D.E., Arnold, M.E., D'Arienzo, C.J., Weinstein, S.H. Pharm. Res. (1991)
- Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter. Lin, C.J., Akarawut, W., Smith, D.E. Pharm. Res. (1999)
- Peripheral hemodynamic and humoral effects of oral zofenopril calcium (SQ. 26,991) in patients with congestive heart failure. Borghi, C., Magelli, C., Boschi, S., Costa, F.V., Capelli, M., Varani, E., Magnani, B., Ambrosioni, E. Journal of clinical pharmacology. (1989)
- Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel. Sargent, C.A., Sleph, P.G., Dzwonczyk, S., Smith, M.A., Normandin, D., Antonaccio, M.J., Grover, G.J. J. Pharmacol. Exp. Ther. (1993)
- Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species. Cominacini, L., Pasini, A., Garbin, U., Evangelista, S., Crea, A.E., Tagliacozzi, D., Nava, C., Davoli, A., LoCascio, V. Am. J. Hypertens. (2002)
- Beneficial effects of ACE-inhibition with zofenopril on plaque formation and low-density lipoprotein oxidation in watanabe heritable hyperlipidemic rabbits. Napoli, C., Cicala, C., D'Armiento, F.P., Roviezzo, F., Somma, P., de Nigris, F., Zuliani, P., Bucci, M., Aleotti, L., Casini, A., Franconi, F., Cirino, G. Gen. Pharmacol. (1999)
- The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patients. Elijovich, F., Laffer, C.L., Schiffrin, E.L. Journal of human hypertension. (1997)
- Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice. de Nigris, F., D'Armiento, F.P., Somma, P., Casini, A., Andreini, I., Sarlo, F., Mansueto, G., De Rosa, G., Bonaduce, D., Condorelli, M., Napoli, C. International journal of cardiology. (2001)
- An Angiotensin-converting enzyme inhibitor, zofenopril, prevents renal ischemia/reperfusion injury in rats. Altunoluk, B., Soylemez, H., Oguz, F., Turkmen, E., Fadillioglu, E. Ann. Clin. Lab. Sci. (2006)
- Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation. Borghi, C., Bacchelli, S., Esposti, D.D., Bignamini, A., Magnani, B., Ambrosioni, E. Am. J. Hypertens. (1999)
- Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors. Borghi, C., Boschi, S., Ambrosioni, E., Melandri, G., Branzi, A., Magnani, B. Journal of clinical pharmacology. (1993)
- The role of zofenopril in myocardial protection during cardioplegia arrest: an isolated rat heart model. Leva, C., Mariscalco, G., Ferrarese, S., Bruno, V.D., Orrù, A., Cattaneo, P., Sala, A. Journal of cardiac surgery. (2006)
- Assay of zofenopril and its active metabolite zofenoprilat by liquid chromatography coupled with tandem mass spectrometry. Dal Bo, L., Mazzucchelli, P., Marzo, A. J. Chromatogr. B Biomed. Sci. Appl. (2000)